Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 20;12(8):1913.
doi: 10.3390/biomedicines12081913.

Nesfatin-1: A Novel Diagnostic and Prognostic Biomarker in Digestive Diseases

Affiliations
Review

Nesfatin-1: A Novel Diagnostic and Prognostic Biomarker in Digestive Diseases

Adriana-Cezara Damian-Buda et al. Biomedicines. .

Abstract

Nesfatin-1, deriving from a precursor protein, NUCB2, is a newly discovered molecule with anti-apoptotic, anti-inflammatory, antioxidant, and anorexigenic effects. It was initially identified in the central nervous system (CNS) and received increasing interest due to its energy-regulating properties. However, research showed that nesfatin-1 is also expressed in peripheral tissues, including the digestive system. The aim of this review is to give a résumé of the present state of knowledge regarding its structure, immunolocalization, and potential implications in diseases with inflammatory components. The main objective was to focus on its clinical importance as a diagnostic biomarker and potential therapeutic molecule in a variety of disorders, among which digestive disorders were of particular interest. Previous studies have shown that nesfatin-1 regulates the balance between pro- and antioxidant agents, which makes nesfatin-1 a promising therapeutic agent. Further in-depth research regarding the underlying mechanisms of action is needed for a better understanding of its effects.

Keywords: anorexigenic; anti-inflammatory; antioxidant; digestive disorders; inflammatory disorders; nesfatin-1.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Nesfatin-1: localization and possible role in tissue functions regulation. Created with BioRender.com (accessed on 1 August 2024).

Similar articles

Cited by

References

    1. Oh-I S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., et al. Identification of Nesfatin-1 as a Satiety Molecule in the Hypothalamus. Nature. 2006;443:709–712. doi: 10.1038/nature05162. - DOI - PubMed
    1. Shimizu H., Oh-I S., Okada S., Mori M. Nesfatin-1: An Overview and Future Clinical Application. Endocr. J. 2009;56:537–543. doi: 10.1507/endocrj.K09E-117. - DOI - PubMed
    1. Foo K.S., Brismar H., Broberger C. Distribution and Neuropeptide Coexistence of Nucleobindin-2 MRNA/Nesfatin-like Immunoreactivity in the Rat CNS. Neuroscience. 2008;156:563–579. doi: 10.1016/j.neuroscience.2008.07.054. - DOI - PubMed
    1. Stengel A., Goebel M., Taché Y. Nesfatin-1: A Novel Inhibitory Regulator of Food Intake and Body Weight. Obes. Rev. 2011;12:261–271. doi: 10.1111/j.1467-789X.2010.00770.x. - DOI - PMC - PubMed
    1. Goebel-Stengel M., Wang L., Stengel A., Taché Y. Localization of Nesfatin-1 Neurons in the Mouse Brain and Functional Implication. Brain Res. 2011;1396:20–34. doi: 10.1016/j.brainres.2011.04.031. - DOI - PMC - PubMed

LinkOut - more resources